Global Point of Care Fertility Testing Market Research Report - Segmented by Type (Human chorionic, Gonadotropin (HCG) urine test, FSH urine test, Human chorionic Gonadotropin (HCG) blood test, Luteinizing hormone (LH) urine test); By Fertility Tests (Line-Indicator, Digital); By Distribution Channel (Hypermarkets & supermarkets, Gynecology & Fertility clinics, Pharmacy, Online sales); By End-User (Hospitals & Clinics, Research Institutes, Diagnostic Laboratories); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Point of Care Fertility Testing Market – Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Point of Care Fertility Testing Market – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
           2.3.1    Impact during 2023 – 2030
           2.3.2    Impact on Supply – Demand
Chapter 3. Point of Care Fertility Testing Market – Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Point of Care Fertility Testing Market - Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
           4.4.1     Bargaining Power of Suppliers
           4.4.2     Bargaining Powers of Customers
           4.4.3    Threat of New Entrants
           4.4.4    .Rivalry among Existing Players
           4.4.5    Threat of Substitutes
Chapter 5. Point of Care Fertility Testing Market - Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Point of Care Fertility Testing Market - By Type
6.1    Human chorionic Gonadotropin (HCG) urine test
6.2    FSH urine test
6.3    Human chorionic Gonadotropin (HCG) blood test
6.4    Luteinizing hormone (LH) urine test
Chapter 7. Point of Care Fertility Testing Market - By Fertility Tests 
7.1    Line-Indicator 
7.2    Digital
Chapter 8. Point of Care Fertility Testing Market - By Distribution Channel
8.1    Hypermarkets & supermarkets
8.2    Gynaecology & fertility clinics
8.3    Pharmacy
8.4    Online sales
Chapter 9. Point of Care Fertility Testing Market - By End-User 
9.1    Hospitals & Clinics
9.2    Research Institutes
9.3    Diagnostic Laboratories
Chapter 10. Point of Care Fertility Testing Market – By Region
10.1    North America
10.2    Europe
10.3    Asia-Pacific
10.4    Latin America
10.5    The Middle East
10.6    Africa
Chapter 11. Point of Care Fertility Testing Market – Key Players
11.1    Alere Inc.
11.2    Quidel Corporation
11.3    Prestige Brands Holdings, Inc. 
11.4    Church & Dwight Co., Inc.
11.5    bioMérieux SA
11.6    Geratherm Medical AG
11.7    Abbott Laboratories
11.8    Procter & Gamble Co.
11.9    DCC Plc.
11.10    Swiss Precision Diagnostics GmbH


 

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800

Frequently Asked Questions

The point of care a sort of medical test known as fertility testing can be carried out at or close to the location of the patient's treatment, such as at home, in a drugstore, or a clinic.

The Global Point of Care Fertility Testing Market was estimated to be worth USD 1.4 billion in 2022 and is projected to reach a value of USD 1.98 billion by 2030, growing at a CAGR of 4.4% during the forecast period 2023-2030.

The dropping fertility rate among men and women and the rising number of women who suffer from conditions including polycystic ovarian syndrome (PCOS) are driving factors in the Global Point of Care Fertility Testing Market.

Factors that are restraining the demand for fertility test kits may slower the growth of the market.

The luteinizing hormone (LH) urine test type is the fastest growing in the Global Point of Care Fertility Testing Market.